BPG is committed to discovery and dissemination of knowledge
Featured Articles
11/17/2022 6:08:26 AM | Browse: 409 | Download: 1511
 |
Received |
|
2022-04-11 20:34 |
|
Peer-Review Started |
|
2022-04-11 20:36 |
|
First Decision by Editorial Office Director |
|
2022-06-27 09:59 |
|
Return for Revision |
|
2022-06-27 09:59 |
|
Revised |
|
2022-07-14 02:27 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2022-09-26 03:46 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2022-10-06 02:35 |
|
Articles in Press |
|
2022-10-06 02:35 |
|
Edit the Manuscript by Language Editor |
|
2022-10-11 18:42 |
|
Typeset the Manuscript |
|
2022-11-16 06:20 |
|
Publish the Manuscript Online |
|
2022-11-17 03:36 |
| ISSN |
2222-0682 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
©The Author(s) 2022. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Surgery |
| Manuscript Type |
Systematic Reviews |
| Article Title |
Impact of gender-affirming hormone therapy on the development of COVID-19 infections and associated complications: A systematic review
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Jennifer J Ferraro, Allie Reynolds, Sylvia Edoigiawerie, Michelle Y Seu, Sydney R Horen, Amir Aminzada and Alireza Hamidian Jahromi |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Alireza Hamidian Jahromi, MD, Doctor, Doctor, Division of Plastic and Reconstructive Surgery, Temple University Health System, 3401 N Broad St., Philadelphia, PA 19140, United States. alirezahamidian@yahoo.com |
| Key Words |
COVID-19; Transgender; Gender-affirming hormone therapy; Gender affirmation; Testosterone; Estrogen |
| Core Tip |
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) can produce a wide range of clinical manifestations from asymptomatic to life-threatening. Differences in individual responses to systemic inflammation and coagulopathy appear to be modulated by several factors, including sex steroid hormones. Androgens may facilitate initial COVID-19 infection, however, once this occurs, testosterone may have a protective effect. The role of estrogen and progesterone has also been proposed as potential protective factors in COVID-19 infection. Few studies have investigated the role of gender-affirming hormone therapy in COVID-19 infections. Additional research is necessary to enhance our understanding of this relationship and provide better care for transgender patients. |
| Publish Date |
2022-11-17 03:36 |
| Citation |
Ferraro JJ, Reynolds A, Edoigiawerie S, Seu MY, Horen SR, Aminzada A, Hamidian Jahromi A. Impact of gender-affirming hormone therapy on the development of COVID-19 infections and associated complications: A systematic review. World J Methodol 2022; 12(6): 465-475 |
| URL |
https://www.wjgnet.com/2222-0682/full/v12/i6/465.htm |
| DOI |
https://dx.doi.org/10.5662/wjm.v12.i6.465 |
All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.
